CD8A and breast cancer: In contrast, higher levels of intratumoral CD8+ T-cells are associated with improved breast cancer-specific survival (HR 0.55 95 % CI, 0.39 to 0.78 p  =  0.001) [7], while the presence of intratumoral Tregs is associated with a worse prognosis across all breast cancer subtypes [8].